Ingevity (NGVT) Accumulated Expenses (2015 - 2026)

Ingevity (NGVT) has 12 years of Accumulated Expenses data on file, last reported at $165.0 million in Q1 2026.

• Accumulated Expenses for Q1 2026 came in at $165.0 million, up 782.35% year-over-year; the trailing twelve-month figure through Mar 2026 was $165.0 million (up 782.35% YoY), and the FY2025 annual result was $148.0 million, up 442.12% from the prior year.
• Accumulated Expenses improved to $165.0 million in Q1 2026 per NGVT's latest filing, from $148.0 million in the prior quarter.
• Over five years, Accumulated Expenses peaked at $165.0 million in Q1 2026 and troughed at $16.6 million in Q1 2024.
• A 5-year average of $60.1 million and a median of $30.6 million in 2022 frame the typical range for Accumulated Expenses.
• The sharpest annual moves came in 2024 and 2026: Accumulated Expenses plunged 69.6% in 2024, then jumped 782.35% in 2026.
• A 5-year view of Accumulated Expenses shows it stood at $54.4 million in 2022, then slumped by 63.42% to $19.9 million in 2023, then soared by 37.19% to $27.3 million in 2024, then soared by 442.12% to $148.0 million in 2025, then increased by 11.49% to $165.0 million in 2026.
• Business Quant data shows NGVT's Accumulated Expenses at $165.0 million in Q1 2026, $148.0 million in Q4 2025, and $159.1 million in Q3 2025.